BTI Liquid 5% AS vs BTI WP 7% Powder Comparison for Municipal Mosquito Control Procurement in India Covering Formulation Differences, Biological Potency, Application Methods, Storage, Packaging

Understanding BTI Liquid 5% AS and BTI WP 7% Powder Formulations

Bacillus thuringiensis subsp. israelensis (BTI) is a biological mosquito larvicide used for controlling susceptible mosquito larvae in approved aquatic breeding environments. BTI Liquid 5% AS and BTI WP 7% Powder are two different formulation types that may be considered by municipal corporations, public health departments and authorized vector control contractors for mosquito larvae management programmes. BTI Liquid 5% AS is supplied as an aqueous suspension formulation, whereas BTI WP 7% is supplied as a wettable powder intended to be dispersed in water according to the registered product instructions. Both formulations contain BTI-derived larvicidal activity, but their physical characteristics, handling procedures, packaging and storage requirements differ.

The declared concentrations of 5% AS and 7% WP should not be interpreted as a direct comparison of biological efficacy. Percentage concentration, viable microbial count and larvicidal potency are different measurements, and a higher declared formulation percentage does not automatically mean greater effectiveness in the field. Government procurement authorities should evaluate each formulation using its registered specifications, applicable biological potency data, approved application instructions and relevant quality documentation. Product selection should be based on the intended municipal programme, authorized use conditions, operational requirements and total procurement considerations rather than concentration percentage alone.

Application Handling, Mixing Requirements and Municipal Field Operations

BTI Liquid 5% AS and BTI WP 7% Powder may require different preparation and handling procedures before field application. Liquid aqueous suspension formulations may require appropriate agitation or mixing as specified by the manufacturer to maintain uniform distribution of the formulation. Wettable powder products generally require dispersion in water according to the approved instructions, with attention to mixing procedures and equipment compatibility. Municipal field teams should follow the registered label for dilution, application rate, application equipment and approved treatment sites. Neither formulation should be applied using an assumed universal dose or preparation method.

Operational considerations may include the type of mosquito breeding environment, available application equipment, field staff training, water access, transport logistics and the frequency of planned treatments. Liquid products may be convenient where equipment and workflows are designed for handling liquid concentrates, while wettable powder products may suit operations equipped for controlled powder measurement and preparation. These are practical considerations rather than guarantees of superior performance. Municipal departments should assess the registered uses and actual product instructions before choosing a formulation for drains, stagnant water, waterlogged areas or other potential breeding environments.

Biological Potency, Quality Testing, Packaging and Storage Comparison

Government buyers should compare BTI Liquid 5% AS and BTI WP 7% Powder using formulation-specific technical documents. A Technical Data Sheet should describe product identity, formulation type, declared concentration, applicable quality parameters and storage instructions. A Certificate of Analysis should identify the tested manufacturing batch and report results using appropriate methods and units. Biological potency should be evaluated using comparable, relevant test information rather than assuming that 7% WP is more potent than 5% AS. Wettable powder quality assessment may include moisture content, wettability and suspension characteristics, while liquid formulation evaluation may include appropriate suspension properties and stability parameters. The exact tests depend on the registered specification and tender requirements.

Packaging and storage are also important differences. BTI Liquid 5% AS requires containers compatible with the aqueous suspension, while BTI WP 7% Powder requires packaging suitable for protecting the powder from moisture and contamination. Both products should be stored according to their respective approved labels and validated manufacturer instructions. Shelf life should be verified separately for each formulation because the two products may have different stability profiles. Municipal warehouses should check manufacturing dates, expiry dates, batch numbers, packaging integrity and any tender-specific minimum remaining shelf-life requirements before accepting deliveries.

Government Tender Evaluation, Procurement Cost and Bulk Supply Decisions

Municipal corporations and government public health departments should evaluate BTI Liquid 5% AS and BTI WP 7% Powder according to the actual tender specifications. Relevant considerations may include product registration, approved public health uses, manufacturer authorization, technical compliance, biological potency documentation, packaging, storage conditions, supply capacity and delivery requirements. Where a tender specifies a particular formulation, bidders should not substitute another formulation without an authorized clarification or amendment. A BTI WP 7% registration certificate does not automatically establish authorization for BTI Liquid 5% AS, and the reverse is also true.

Procurement cost comparisons should consider more than the quoted price per litre or kilogram. Where the necessary data are available, buyers may evaluate the cost of achieving the required authorized treatment coverage, including product potency, label application rates, preparation requirements, equipment, labour, transportation, storage and potential wastage. Any comparison must use equivalent treatment objectives and valid product-specific information. Bactostore India welcomes enquiries from municipal corporations, government public health departments, institutional purchasers and authorized vector control contractors regarding BTI Liquid 5% AS and BTI WP 7% Powder technical information, formulation differences and potential bulk procurement arrangements.